18F-FDG PET in pediatric lymphomas: A comparison with conventional imaging

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 6, 2008, Pages 681-689

  Lopci, Egesta ^a   Burnelli, Roberta ^b   Ambrosini, Valentina ^a   Nanni, Cristina ^a   Castellucci, Paolo ^a   Biassoni, Lorenzo ^c   Rubello, Domenico ^d   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

18F FDG PET; Conventional imaging; Follow up; Pediatric lymphoma; Response to therapy; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISEASE COURSE; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; INFANT; INFLAMMATION; INTERMETHOD COMPARISON; MALE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

ADOLESCENT; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58549099872     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0519     Document Type: Article

References (23)

1. Magnani C, Gatta G, Corazziari I, et al. Childhood malignancies in the EUROCARE study: The database and the methods of survival analysis. Eur J Cancer 2001;37:678.
2. Hudson MM, Donaldson SS. Hodgkin's disease. Pediatr Clin N Am 1997;44:891.
3. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238.
4. Jaffe E, Harris N, Stein H, eds. World Health Organization Classification of Tumors. Tumours of Haematopoietic and Lymphoid Tissues. Washington, DC: IARC Press, 2000.
5. Cairo MS, Raetz E, Perkins SL. Non-Hodgkin's lymphoma in children. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., eds. Cancer Medicine E. 6. London: B C Decker Inc, 2003.
6. Schwartz CL. Special issues in pediatric Hodgkin's disease. Eur J Haematol 2005;75(Suppl. 66):55.
7. Jadvar H, Connolly LP, Fahey FH, et al. PET and PET/CT in pediatric oncology. Sem Nucl Med 2007;37:316.
8. 18F] FDG in childhood lymphoma: Clinical utility and impact on management. Eur J Nucl Med 2002;29:1155.
9. Schellong G, Potter R, Bramswig J, et al. The German-Austrian Pediatric Hodgkin's Disease Study Group High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. J Clin Oncol 1999;17:3736.
10. Dorffel W, Luders H, Ruhl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 2003;215:139.
11. Thomson AB, Wallace WHB. Treatment of pediatric Hodgkin's disease: A balance of risks. Eur J Cancer 2002;38:468.
12. 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 2005;32:31.
13. Pinkerton R. Continuing challenges in childhood non-Hodgkin's lymphoma Br J Haematol 2005;130:480.
14. Hermann S, Wormanns D, Pixberg M, et al. Staging in childhood lymphoma: Differences between FDG-PET and CT. Nuklearmedizin 2005;44:1.
15. Meany HJ, Gidvani VK, Minniti CP. Utility of PET scans to predict disease relapse in pediatric patients with non-Hodgkin's lymphoma. Pediatr Blood Cancer 2007;48:399.
16. Levine JM, Weiner M, Kelly KM. Routine use of PET scans after completion of therapy in pediatric Hodgkin's disease. Results in a high false-positive rate. J Pediatr Hematol Oncol 2006;28:711.
17. Hernandez-Pampaloni M, Takalkar A, Yu JQ, et al. F-18 FDG-PET imaging and correlation with CT in syaging and follow-up of padiatric lymphomas. Pediatr Radiol 2006;36:524.
18. 18F]-FDG positron imaging in clinical management of lymphoma patients. Crit Rev Oncol Hematol 2001;38:193.
19. 18F-FDG PET/CT fusion imaging in pediatric solid extracranial tumours. Biomed Pharmacother 2006;60:593.
20. Kabickova E, Sumerauer D, Cumlivska E, et al. Comparison of (18) F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Eur J Nucl Med Mol Imaging 2006;33:1025.
21. 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients. J Comput Assist Tomogr 2006;30:689.
22. Truong MT, Erasms JJ, Munden RF, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. AJR Am J Roentgenol 2004;183:1127.
23. Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of non-Hodgkin's lymphoma. Haematology 2006;91:482.